Why did Nvidia resume AI chip sales to China?
How are Trump's tariffs impacting US inflation?
What caused JPMorgan’s profit to fall despite beat?
Why are crypto bills stalling in the House?
How will Apple’s rare-earth deal affect supply chains?
What’s behind Tesla’s North American sales leadership exit?
How did BlackRock’s big client redemption affect shares?
Wolfe Research Affirms Outperform Rating on Johnson & Johnson (JNJ) on Improving Fundamentals
finance.yahoo.com/news/wolfe-research-affirms-outperform-rating-131031975.html
In This Article:
Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research reiterated an ‘Outperform’ rating on the stock and a $175 price target. The bullish stance underscores the company’s strong performance year to date…
This story appeared on finance.yahoo.com, 2025-07-15 13:10:31.